The Monitoring Office for Technological Measures (OTM) is the specialist authority of the federal government for determining the effects of technological measures such as access control or copy barriers when using copyrighted content (music, films, etc.). A copy barrier can, for example, prevent an audio book from being saved on an MP3 device.
The task of the OTM is to assess whether the use of technological measures unjustifiably impedes the use of works expressly authorised by law. In the event of a specific case, a mutually agreeable solution will be developed in cooperation with the parties involved.
As part of the Digital Switzerland Action Plan, the OTM examined the extent to which consumers are unjustifiably prevented from accessing films, series or sports broadcasts when staying abroad. Their findings have been published in a report (German, French, and Italian, pdf). The OTM found that it is not always possible to access films etc. when staying in another country. From the OTM's point of view, all parties concerned have interests that are justifiable. As the situation is still in flux, legislative action is currently not advisable. The OTM will therefore continue to monitor the situation and will inform the Federal Council of the developments by the end of 2023.
Monitoring Office for Technological Measures
Telephone +41 31 377 72 59
- Media release in German "Beobachtungsstelle für technische Massnahmen wird ins IGE überführt" (PDF)
- Media release in French: "Transfer de l'Observatoire des mesures techniques à l'IPI" (PDF)
- Media release in Italian: "L'Osservatorio dei provvedimenti tecnici sarà accorpato all'Istituto federale della prorietà intellettuale" (PDF)
Study shows that points of contact for Swiss inventors and creatives score highly
01.01.2021 | Law and policy
The sic! journal in partnership with the Helbing Lichtenhahn Verlag from 2021
The ‘Swiss’ brand is adequately protected
Swiss Innovation Forum 2020 to be held as an online festival
08.11.2019 | Event
Symposium on Creative Approaches to Improving Access to Medicines Globally